Inventor of mRNA technology argues against vaccine-risk censorship, offers a dynamic approach to combatting COVID-19

Dr. Robert Malone has over 30 years of experience as an internationally recognized scientist of virology, immunology, and molecular biology. Malone holds numerous fundamental patents in those respective fields. His ground-breaking contribution to the development of the mRNA technologies give him an insightful perspective on the role of emerging vaccines in the fight against COVID-19. Recently, Malone had a conversation at the Global COVID Summit, to explain these ideas.

Good Science and Medicine Should Welcome Open Discussion of Risks

While the COVID-19 vaccines play an important role during this pandemic, Malone finds it problematic to censor necessary (and previously customary) medical discussions regarding potential risks, evolving data, and other promising treatment options.

Though Malone acknowledges the severity of the COVID-19 virus, that doesn’t compromise his standards when it comes to upholding the ethics surrounding the development of new vaccines.

“Full disclosure of risks,” is the “fundamental pillar of bioethics” which must be communicated to the public in a way they can understand, says Malone. Individuals must be “free, unencumbered, and non-coerced.” In this manner, people can willfully consent to the experimental medical procedure.  “I feel ethically bound to say no, this isn’t right.”

“We are in the middle of the largest experiment on human beings that has ever been performed…” says Malone. A new vaccine being administered to an enormous portion of the world population should be a reason to exercise more caution.

One main reason Malone is advocating for more selective-vaccine intake is those troublesome, evasive variants.

COVID Variants: A Dynamic Virus Calls for a Dynamic Strategy

Data on COVID-19 is evolving as rapidly as the virus itself.  World health organizations that rely on firmly established data are “making decisions that are totally inappropriate during the dynamic environment of an outbreak,” says Malone, since firmly established data is usually about six months behind.

Thankfully, other key players in science and medicine still embrace the concept of exploring newly emerging data on vaccine performance, potential risks, and perplexing variants, to better understand and overcome COVID-19.  

Geert Vanden Bossche, for example, is a leading advocate for the theory that variants of COVID-19 are being produced through vaccination. “I highly respect his insight,” says Malone.

“Viruses that have evolved to escape vaccine effects, will only do so in response to having reproduced and been selected in the body of people who have received the vaccine. This is fundamental Darwinian evolution,” says Malone.

Developing variants were tracked “largely in geographic regions and the time when the vaccine was being selectively deployed for clinical trials. Then, when we introduced the mass vaccination event, the divergents and evolution of those variants explode.”

The difference in the efficacy regarding how traditional live-attenuated vaccines work, (such as Polio, Yellow Fever, and Smallpox,) as opposed to mRNA vaccines, is that the former are administered prior to a major outbreak, preventing opportunity to spread.

“But once the virus is already embedded into a large fraction of the population, that logic fails.” Ultimately, vaccinating during an outbreak drives more potent mutations.

Another advantage of traditional vaccines is that they express a robust variety of proteins to attack the virus. In comparison, mRNA and adenovirus vaccines use the same basic gene-therapy technology with the exact single-antigen protein: spike.

“Logically what we’re doing is driving the development of viruses that can escape the immune surveillance associated with the spike.”

This explains why natural immunity proves to be 10 to 20 times more powerful than vaccine immunity. “The data shows this clearly,” says Malone. Therefore, vaccinating people who have recovered from COVID-19 does not make sense from a scientific, immunological perspective. Yet, world health leaders ignore this information.

Potential Dangers to Reproductive Health

The CDC website discloses the fact that no studies were ever conducted on pregnant or breastfeeding women. Additionally, in the interest of time, the FDA bypassed several rounds of rigorous animal testing to screen for toxicity in vital organs.

However, studies from Japan (in rodent testing) revealed that the synthetic chemical responsible for driving the vaccine, “accumulates paradoxically in the ovaries,” says Malone.

For this reason, Malone says world health organizations should be transparent that risks to reproductive health are unknown, as opposed to saying they are definitively safe. “I object to this.”

The native spike protein of the virus is a toxin, but to a lesser degree, so is the vaccine. Both can open the blood-brain barrier and producing coagulation.

Potential complications during pregnancy may occur because the uterus and the placenta are very vascular organs. If micro-coagulation (small blood clots) develops all over these areas, it has the potential to disrupt the oxygen and food supply. This can lead to a multitude of complications with fetal development: spontaneous abortion, disruption of physical and neurological development, as well as posing additional risks to the mother.

However, it is important to note, that the virus itself can create the same problems, and probably to a more severe degree. Those risks should be weighed by the patient and their OB.

Here are Malone’s recommendations for family planning and risk mitigation during the pandemic:

Find “a physician who is willing to give early treatment in case of infection.”

For women who feel that the vaccine is still appropriate, (or mandated) get your doses before becoming pregnant.

Already pregnant? Quarantine during first and second trimesters, then vaccinate during the third trimester, or after delivery. Since mRNA products are shed in breastmilk, parents must consider the unknown risk as to how this will affect infant development.

Malone’s Multi-Pronged Approach to Combatting COVID-19

Vaccines for those who need it

The limited supply of vaccines should be given to those who are most at-risk around the globe: the elderly, the immunocompromised, and the morbidly obese. Though the vaccines are not perfect, it is most valuable for these groups.

Preventative drug treatments for the general population

With promising new drugs, combinations, and treatments emerging, those need to be utilized (instead of discouraged) to keep people from hospitalization.

Introduce easily accessible home testing

At-home testing should be more accessible because it can speed up the time to get the necessary medication while helping those with a contagious infection to keep from spreading it to others.

Empower people with tools to overcome fear

“We need to have a way so that people can get a realistic assessment of what is their true risk, as opposed to what they fear based on the media. People are being driven crazy.” Malone references online apps that can help determine your risk to make an informed, rational decision.

Our Future with COVID-19

“The Director of the WHO fully concedes we cannot overcome this virus. This virus is going to be part of the human population for the rest of our lives…” says Malone. “Then let’s be intelligent about it. Let’s be strategic and tactical, and use all the tools that we have, and make sure we apply them in the right way.”

“We should practice medicine based on the individual, and their risks, and their health. We should empower people to make decisions, not to dictate to them about what those decisions should be.”